A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB

被引：0
|
作者：
Menefee, Michael E. [1 ]
D'Amico, Thomas A. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
KRAS; Crizotinib; NSCLC; EML4-ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-033
引用
收藏
页码：S1315 / S1316
页数：2
相关论文
共 50 条
  • [21] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [22] Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?
    Antoniu, Sabina Antonela
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 351 - 353
  • [23] Clinicopathological features of younger (aged 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene
    Kometani, Takuro
    Sugio, Kenji
    Osoegawa, Atsushi
    Seto, Takashi
    Ichinose, Yukito
    THORACIC CANCER, 2018, 9 (05) : 563 - 570
  • [24] ALK inactivation induced acquired resistance to alectinib in lung cancer harboring EML4-ALK fusion gene
    Isozaki, Hideko
    Ichihara, Eiki
    Yasugi, Masayuki
    Nobuaki, Ochi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Sendo, Toshiaki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER RESEARCH, 2014, 74 (19)
  • [25] A Case of Lung Adenocarcinoma Response to Alectinib Harboring a Rare EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
    Liu, Lirong
    Hou, Fangfang
    Liu, Yufeng
    Li, Wenzhu
    Zhang, Haibo
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (01): : 2 - 6
  • [26] Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung
    Batra, U.
    Sharma, M.
    Jain, A.
    Agarwal, M.
    Goyal, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Identification of a Novel EML4-ALK Fusion Transcript in Lung Adenocarcinoma
    To, K.
    Tong, J. H. M.
    Law, P. P. Y.
    Chau, S. L.
    Lung, R. W. M.
    Yeung, S. F.
    Kang, W.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S218 - S219
  • [28] Pulmonary Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene
    Sokai, Akihiko
    Enaka, Makiko
    Sokai, Risa
    Mori, Shoichi
    Mori, Shunsuke
    Gunji, Masaharu
    Fujino, Masahiko
    Ito, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 93 - 96
  • [29] EML4-ALK Fusion in Lung Reply
    Falini, Brunangelo
    Martelli, Maria Paola
    Pileri, Stefano A.
    Sozzi, Gabriella
    Gasparini, Patrizia
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1553 - 1554
  • [30] Analysis of ERBB Ligand-Induced Resistance Mechanism to Crizotinib by Primary Culture of Lung Adenocarcinoma with EML4-ALK Fusion Gene
    Kimura, Madoka
    Endo, Hiroko
    Inoue, Takako
    Nishino, Kazumi
    Uchida, Junji
    Kumagai, Toru
    Kukita, Yoji
    Kato, Kikuya
    Imamura, Fumio
    Inoue, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (03) : 527 - 530
12345